Infosys Limited
Quality (80/100) does the heavy lifting; momentum (8/100) is the drag.
Buy zoneOvervaluedOur blended model reads Infosys Limited as a Hold at 45/100. At ₹1,037.7 it trades above our blended DCF and relative-multiples fair value of ₹726.99, about 30% downside to that estimate — we read it as overvalued by 30%. On 14.0x trailing earnings it sits cheaper than the Technology median of about 20.0x. The price is about 37% below its 52-week high of ₹1,654.01 and 5% above the low of ₹985.3. Financial health scores 100/100, in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9. The average analyst target of ₹1,460.95 implies about 41% upside across 40 analysts. It clears 7 of 14 investability checks, with durability 80, valuation 73 and momentum 8 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹581.59. Low-confidence estimate — limited data.
Analyst views
1-year price
EOD · 2026-09-1252-week range
-37.26% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold45Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 31.4%
- Pass: Low debt (D/E < 0.5): 0.10x
- Pass: Positive free cash flow
- Fail: Revenue growth > 10%: 7%
- Pass: Earnings growing: 12%
- Pass: Net margin ≥ 10%: 16.4%
- Pass: Current ratio > 1.5: 1.98
- Fail: Below our fair value
- Fail: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- Fail: Positive 1-year return
- Pass: Altman Z in safe zone: Z 498.73
- Fail: Piotroski ≥ 7: 4/9
Quarterly results
Annual financials
Shareholding
- Promoter16.4%
- Institutions51.8%
- Public & other31.8%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (31.4%).
- Lightly leveraged balance sheet.
- Healthy profit margin (16.4%).
- Financially solid — Altman Z 498.73.
Opportunities
- Trading in our value buy zone versus sector peers.
- Well off its 52-week high — possible mean-reversion.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
- Down 29% over the past year.
Threats
- Trades ~30% above our estimated fair value.
About Infosys Limited
Infosys Limited offers consulting, technology, outsourcing, and digital services globally, including digital marketing, commerce, and workplace solutions; data analytics and AI capabilities; blockchain and IoT; and enterprise modernization services spanning cloud migration, API development, and digital automation.
Infosys Limited — frequently asked questions
Is Infosys Limited a buy, hold or sell?
StocksWizard currently rates Infosys Limited (INFY) a Hold, based on a blended score of 45/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Infosys Limited's fair value?
Our blended DCF and relative-valuation model estimates Infosys Limited's fair value at about ₹726.99, versus a current price of ₹1,037.7 — roughly 30% downside. On that basis the stock looks overvalued by 30%.
Is Infosys Limited financially healthy?
Infosys Limited scores 100/100 on our financial-health model, placing it in the safe band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Infosys Limited's share price performed?
Infosys Limited is down 29% over the past year and down 9% over three months, and last traded at ₹1,037.7. Past performance doesn't predict future returns.
More in Technology
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.